 |
-
Outlook for Medical Devices & Diagnostics: David Nexon, Advanced Medical Technology Association (AdvaMed)
-
HealthShares ETF: Jeffrey L. Feldman, XShares Advisors LLC
-
Promoting Life Sciences in Washington State: Dr. Jack Faris, Washington Biotechnology & Biomedical Association
-
CEO Interviews (average 2,500 words): Top management from 29 sector firms examine the outlook for their firm and sector. Firms interviewed include: Accium BioSciences, Inc., Adnavance Technologies Inc., Advanced Imaging Technologies, Inc., Aequus BioPharma, Inc., Aquinox Pharmaceuticals Inc., Calistoga Pharmaceuticals, Inc., CardioMetabolics Inc., CG Therapeutics, Inc., Chemokine Therapeutics Corp., Dimera Incorporated, Electrical Geodesics, Inc., Floragenex, GenoLogics Life Sciences Software Inc., Healionics Corporation, Healix BioMedix, Inc., Mediquest Therapeutics, Inc., MotionBack, Inc., Nastech Pharmaceutical Company, Inc., OncoGenex Technologies Inc., Oncothyreon, Inc., Pacific BioScience Laboratories, Inc., Pathway Medical Technologies, Inc., Response Biomedical Corporation, Seattle Genetics, Inc., SonoSite, Inc., Spaltudaq Corporation, The Vaccines Company Ltd., Vesticon, VLST Corporation.
ORDER THIS REPORT NOW! CLICK HERE
|
|
Investors and Industry Execs.
The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.
TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best.
Money manager interviews provide the view from the buy-side.
CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.
Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.
Sincerely,
Andrew Pickup
Publisher
|
|
|
